While scientific studies about obesity and general health are on the rise, a new analysis has determined that more studies ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...

He examines the true causes of obesity-related disease, the potential and limitations of GLP-1s, and how a more nuanced ...

Recent research shows that fructose in ultra-processed foods may drive disease, like metabolic syndrome, which includes ...

Many people know that obesity carries certain health risks, as it makes you more likely to develop diabetes, heart disease, stroke and certain cancers. But fresh research being presented at this ...

New research reveals that obesity affects men and women in surprisingly different ways. Men are more likely to develop harmful abdominal fat and signs of liver stress, while women show higher ...

Obesity is linked to increased cancer risk through inflammation, metabolic dysfunction, and immune changes. Dr. Jennifer ...

Has the arrival of GLP-1 analogs signaled the end of obesity research? That provocative question framed a session on January 15 at the French Association for the Study of Obesity (AFERO) congress. In ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...

Dr. Gang Hu, Director of the Chronic Disease Epidemiology  Laboratory at Pennington Biomedical Research Center, has been ...

New research to be presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that living ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...